This Week in Psychedelics - 9.24.21

Cannabis

• Switzerland’s Zurich to Begin Recreational Cannabis Trial in 2022 (High Times)

• U.S. House Approves SAFE Banking Act as Part of Military Spending Bill in Historic Vote (High Times)

• Green Party in Finland Calls for End of Prohibition (High Times)

• This company is smuggling tons of legal cannabis into streets, whistleblower alleges (Leafly)

• California State Fair Will Host Marijuana Competition For The First Time At 2022 Event, Officials Announce (Marijuana Moment)

• Connecticut: Qualified Patients Can Begin Home Cultivating Cannabis Next Week (NORML)

• Rhode Island Lawmakers Are ‘Very Close’ On Marijuana Legalization Deal Ahead Of Possible Special Session, Top Senator Says (Marijuana Moment)

• Lessons the Psychedelics Industry Can Learn From the Cannabis Market Bubble (Lucid News)

• Pennsylvania Senators Discuss Bill To Provide DUI Protections For Medical Marijuana Patients (Marijuana Moment)

• VA sending mixed messages for vets about cannabis use to treat PTSD (Arizona Mirror)

• Delaware: Governor Signs Measure Amending Cannabis Penalties for Minors (NORML)

• FBI Clarifies That Using Marijuana More Than 24 Times Disqualifies Would-Be Agents (Marijuana Moment)

• Former Massachusetts Mayor Sentenced for Extortion (High Times)

• Controlling cannabis and the classification of Delta-8 THC (Reuters)

• Eaze launches California program to bring free medical cannabis to low-income patients (Greenway Magazine)

• Mississippi Lawmakers Reach Deal On Medical Marijuana Legalization, Plan To Request Special Session (Marijuana Moment)

• For Chronic Pain Sufferers, Cannabis "May Be a Source of Hope" (Green Entrepreneur)

• Full-Page Washington Post Ad Calls For Marijuana Prisoner’s Freedom While Celebs Make Money In Industry (Marijuana Moment)

• Can Cannabis Help Your Gut? (TIME)

• Florida Marijuana Activists File New Legalization Initiative For 2022 Ballot Following Supreme Court Defeats (Marijuana Moment)

• Oklahoma Activists Finalize Language For Two 2022 Marijuana Ballot Initiatives (Marijuana Moment)

• Nebraska Cannabis Association launches as state's first lobbying group for marijuana-based businesses (York News-Times)

Magic Mushrooms

• Psilocybin Study for Tobacco Gets Federal Funding (Truffle Report)

• Thousands attend first-ever psychedelic shroom festival in Ann Arbor (MLive.com)

• Canadian Coalition Submits Draft for Legal Psilocybin Therapy (Truffle Report)

• Happy Global Magic Mushroom Day (9/20) for Psilocybin Fans (CelebStoner)

• Nine Perfect Strangers's Portrayal of Psilocybin Could Derail Progress in Researching Psychedelic Use for Mental Health (Teen Vogue)

• Shroom Delivery is Now a Thing (DoubleBlind)

• Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac (Newsweek)

• Former GOP Congresswoman Touts Psilocybin As Treatment For Alcoholism (Marijuana Moment)

• Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1 (Psilocybin Alpha)

• Amanita muscaria – A Fresh Look at An Iconic Mushroom (Psychedelic Science Review)

• The 25 Best U.S. Counties for Mushroom Foragers (moveBuddha)

• MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration (Psilocybin Alpha)

• Eversio Wellness Harvests Its First Legally Grown Psychoactive Mushrooms (Yahoo! Finance)

MDMA

• Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London (Psilocybin Alpha)

DMT

• Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy (Psilocybin Alpha)

5-MeO-DMT

• I Wanted Ego Death. This Powerful Psychedelic Gave It To Me. (BuzzFeed News)

• Lexston Initiates Research and Development Project Using Psychedelic Compound 5-Me0-DMT (TheNewswire)

Mescaline

• Mescaline, Veganism, and Schopenhauer’s Philosophy (Sam Woolfe)

Iboga

• DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder (Psilocybin Alpha)

Salvia Divinorum

• Salvia Divinorum and Kratom Combination – What You Must Know About It (IRN Post)

Novel Psychoactive Substances

• Are Prodrugs the Next Wave of Psychedelic Drug Development? (Psychedelic Science Review)

• Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its 5-MeO-DMT-Inspired Drug Candidate, MSP-4018 (Psilocybin Alpha)

• Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders (Psilocybin Alpha)

• Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug (Yahoo! Finance)

• Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data (Psilocybin Alpha)

Synthetic Cannabinoids

• Spice is significantly more harmful than marijuana (International Business Times)

• New Study Comparing Plant-Derived and Synthetic CBD Efficacy Opens Door to Exciting Medical Uses of Cannabidiol (Yahoo! Finance)

Nitrous Oxide

• TikTok Is Hosting Ads for ‘Whipped Cream’. But It’s Actually Nitrous Oxide (VICE)

Ketamine

• Delic signs US$10 million merger deal to become top psychedelic wellness chain in the U.S. (Canadian Lawyer)

• Turning Everyday Therapist Offices into Ketamine Clinics (Lucid News)

• Statistical model defines ketamine anesthesia’s effects on the brain (MIT News)

• Is A Ketamine Infusion Covered By Insurance? (Healing Maps)

Miscellaneous

• Companies are Getting Rid of Drug Tests Because They Can’t Find Enough Workers (VICE)

• Class A drug possession ‘effectively decriminalised’ in Scotland (The Times)

• Hamilton Morris Hired by Psilocybin Startup COMPASS Pathways, Ends "Hamilton's Pharmacopeia" On Vice (Psymposia)

• Italian Advocates Collect 500,000 Signatures for Decriminalization of Cannabis and Psychoactive Substances (High Times)

• Psychedelics Are a Billion-Dollar Business, and No One Can Agree Who Should Control It (VICE)

• Meet Microdosing TikTok—And Why the Community Matters (Psychedelics Today)

• More Michigan Cities Look to Decriminalize Psychedelics (Truffle Report)

• The Michigan Poison and Drug Information Center issues notification about effects and risks of using psychedelic substances (Today@Wayne)

• Criticism of Awakn Treatment Model as Second Clinic Opens for Treating Addiction (TalkingDrugs)

• Psychedelic Patents: Nature, IP Law, & Exclusion (Truffle Report)

• How To Come Down From A High: Navigating the Downslope of a Trip (DoubleBlind)

• Armed With Two Patents, Psycheceutical Plans To Transform Psychedelic Drug Delivery (Forbes)

• Psychedelic Water founder looks to new legal era for powerful drugs (The Washington Times)

• Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies (Psilocybin Alpha)

• Why Bristol Uni is taking a more progressive stance on drugs (The Bristol Cable)

• Numinus Completes Acquisition of Neurology Centre of Toronto (Psilocybin Alpha)

• The Removal of the Ecuadorian Drug Possession Table: A Major Government Mistake (TalkingDrugs)

• ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 5.14.21

Cannabis

• Republicans Push for Federal Legalization of Marijuana to Ensure 'Individual Liberty' (Newsweek)

• Minnesota House Approves Marijuana Legalization Bill (Marijuana Moment)

• Kansas Senate Running Out Of Time To Pass Medical Marijuana Legalization Bill That Cleared House (Marijuana Moment)

• Nebraska Activists Relaunch Medical Marijuana Ballot Campaign After Legislative Filibuster Blocks Bill (Marijuana Moment)

• Louisiana: House Lawmakers Advance Marijuana Decriminalization Legislation (NORML)

• Cherokee Nation Just Decriminalized Weed Possession in State Where Pot Is Still Illegal (MERRY JANE)

• Feds Announce New Standard THC Dose To Be Used In Marijuana Research, Effective Immediately (Marijuana Moment)

• Ignorance Still Plagues The Field Of Cannabis Medicine (Forbes)

• America’s most conservative states are embracing medical pot (Politico)

• Georgia: Governor Signs Legislation into Law Expanding Access to Low-THC Medical Cannabis (NORML)

• Medicinal cannabis improves quality of life, finds largest study of UK patients (Cannabis Health News)

• Cannabis may slightly reduce RA disease activity based on 'very uncertain' evidence (Healio)

• Don’t Bring CBD Pet Shampoo Onto Military Bases, U.S. Air Force Warns (Marijuana Moment)

• Understanding the History of Rastafari and the Sacramental Use of Ganja with Jahlani Niaah (Chacruna)

Magic Mushrooms

• How Psychedelic Mushrooms Went from Schedule I to Psychotherapy (The Pacific Index)

• Who’s in Charge of Psilocybin? (Chacruna)

• OHSU doctors study how psilocybin interacts with other meds (KATU)

• Havn Life Develops New Method for Rapid Psilocybin Testing (StreetInsider.com)

• Cybin Advances Psilocybin as Treatment for Depression and Addiction (Innovation and Tech Today)

• Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application (Psilocybin Alpha)

MDMA

• MDMA Shows New Promise for Trauma, but the Drug Alone Is Not a Cure (Scientific American)

DMT

• Small Pharma on conducting world’s first clinical trials for psychedelic DMT and listing in Canada (Proactive Investors)

5-MeO-DMT

• Hunter Biden’s Admission Of Toad Venom Use Signals A Sea Change For Addiction Treatments (Lucid News)

Peyote

• Decriminalize Nature Releases Peyote Conservation Plan (Truffle Report)

• Open Letter to the Psychedelic Movement Regarding Peyote in Policy Efforts and How to be an Ally to Indigenous Peoples of North America (Chacruna)

Novel Psychoactive Substances

• Potentially Non-Hallucinogenic Psychedelic Could Open Door for Treatment Developments (Psychiatry and Behavioral Health Learning Network)

Synthetic Cannabinoids

• China issues total ban on synthetic cannabinoids (Seattle Times)

Nitrous Oxide

• Municipality of Amsterdam to ban laughing gas (I Am Expat)

Ketamine

• Colorado lawmakers move to restrict law enforcement’s use of Ketamine (KKTV)

• Delic's Acquisition Target, Ketamine Infusion Centers, Announces Proposal to Acquire 2 Additional Clinic Locations (Yahoo! Finance)

Miscellaneous

• The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same. (The New York Times)

• Drug Possession Is Officially A Crime Again In Washington, But As A Misdemeanor Instead Of Felony (Marijuana Moment)

• Drug Advice Is Better Than Government Approach of 'Just Doing Nothing', Research Finds (VICE)

• How this NHL star’s brain trauma led him to found a psychedelics startup (Fast Company)

• Aspen City Council not quite sold on decriminalizing psychedelics (Aspen Daily Times)

• Some people with color blindness report improved color vision after psychedelic drug use (PsyPost)

• How a Psychedelic 12-Step Program Is Saving Lives (Rolling Stone)

• Psychedelic Therapy for Borderline Personality Disorder? (Psychedelic Science Review)

• An Introduction to Psychedelic Phenethylamines (Spirit Pharmacist)

• Anaïs Nin and the Vocabulary of the Psychedelic Experience (Chacruna)

• Psychedelics Move to The Forefront of Innovative Research as the FDA Approves Large-Scale Testing (PR Newswire)

• Psychedelic Intellectual Property (Reality Sandwich)

• Routes of Administration in Psychedelic Drug Research (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.5.21

Cannabis

• Democratic Senate Leaders Announce Steps To Federally Legalize Marijuana In 2021 (Marijuana Moment)

• Idaho Senate Passes Measure To Block Marijuana Legalization, Even If Voters Approve It On The Ballot (Marijuana Moment)

• Marijuana Legalization Bills Headed to Virginia Senate and House (Filter)

• Top Minnesota Lawmakers File Marijuana Legalization Bill For 2021 (Marijuana Moment)

• New Mexico Senators File Two Marijuana Legalization Bills, With More On The Way (Marijuana Moment)

• Maryland Marijuana Legalization Bill Sponsored By Senate President And Other Top Lawmakers (Marijuana Moment)

• Alabama Senate Committee Approves Medical Marijuana Legalization Bill (Marijuana Moment)

• Sustainability In The Cannabis Industry: Truly Going Green (Forbes)

• Clinical Trial: Whole-Plant Cannabis Extracts Associated with Improved Outcomes in Autistic Patients (NORML)

• The “Secret Handshake”—A Program Gifting Cannabis to Unhoused People (Filter)

• Adult-Use Marijuana Legalization Not Associated with Any Rise in Substance Abuse Treatment Admissions (NORML)

• Mississippi’s high court to hear arguments to block medical cannabis (Marijuana Business Daily)

• Philadelphia: Marijuana Treatment Admissions Drop Eighty Percent (NORML)

LSD

• Neuroscience study indicates that LSD “frees” brain activity from anatomical constraints (PsyPost)

• Diamond Therapeutics Signs Agreement with McGill University for Research on Low-Dose LSD (Psilocybin Alpha)

Magic Mushrooms

• New Jersey Governor Signs Psilocybin Bill To Immediately Reduce Penalties For Possession (Marijuana Moment)

• Psychedelic Mushroom Bills Filed In Florida And Connecticut As Movement Expands To Multiple States (Marijuana Moment)

• Federal Judge Decides Against Prison for Denver Mushroom Dealer (Westword)

• Psilocybin and Neurogenesis: The Long-Term Effects of Magic Mushrooms on Your Brain (Entheonation)

• COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy (GlobeNewswire)

MDMA

• MDMA and psilocybin not approved for medicinal use in Australia (9News)

• MDMA-Assisted Therapy is Less Effective if You Take Antidepressants (DoubleBlind)

DMT

• Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT “The Spirit Molecule” (Psilocybin Alpha)

• Why Does DMT Pervade Nature? (Reality Sandwich)

Ayahuasca

• The Ancestral Healing Power of Ayahuasca (Psychedelic Science Review)

5-MeO-DMT

• Psychedelic Toads Pushed To The Limit, Conservationists Urge Synthetic 5-MeO-DMT Option (Forbes)

Novel Psychoactive Substances

• Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into in vivo PoC Studies (Psilocybin Alpha)

Nitrous Oxide

• Nitrous Nation (The New York Times)

Ketamine

• Proposed law could bar SC 1st responders from using ketamine to incapacitate suspects (The Post and Courier)

• PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine (Psilocybin Alpha)

• PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA for the Clinical Development of Ketamine in the Treatment of Parkinson’s Disease (Psilocybin Alpha)

• Psychedelic Wellness-Focused Company Delic to Acquire Ketamine Infusion Centers LLC (PR Newswire)

• Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas (BioSpace)

Miscellaneous

• Drug Decriminalization Goes Into Effect in Oregon (Rolling Stone)

• Cambridge City Council Decriminalizes Psychedelics And Urges Police To End Drug Arrests More Broadly (Marijuana Moment)

• Washington Lawmakers Introduce Long-Awaited Bill To Decriminalize All Drugs And Expand Treatment (Marijuana Moment)

• Mass General Launches New Center to Study Psychedelics in Psychiatry (Massachusetts General Hospital)

• Psychedelics as Antidepressants (Scientific American)

• Health Canada considers amending Special Access Program (Psillow)

• QAnon shaman turns against Trump, says he would testify that president incited Capitol riots (National Post)

• Biden Quietly Announces Harm Reduction Among His Drug Priorities (Filter)

• Timothy Leary’s Castalia Foundation Has Been Co-opted to Promote Conspiracy Theories about COVID and Elite Pedophile Rings (Psymposia)

• Tryp Therapeutics Appoints Dr. Robin Carhart-Harris to Scientific Advisory Board (Psilocybin Alpha)

• Neuroscience students launch Psychedelic Society (The Glasgow Guardian)

• Pharmacological Testing in Psychedelic Research (Psychedelic Science Review)

• How To Setup Music for Psychedelic Sessions (+ 6 More Playlists for Psilocybin) (Maps of the Mind)

• Marlene Dobkin de Rios: A Case for Complex Histories of Women in Psychedelics (Chacruna)

• Is Microdosing Psychedelics the Secret to Sobriety? (MEL Magazine)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.23.20

Cannabis

• Virginia: Medical Cannabis Dispensing Begins (NORML)

• Missouri medical marijuana dispensaries open to long lines, happy patients (Leafly)

• Montana Supreme Court Rejects Challenge To Marijuana Legalization Initiative (Marijuana Moment)

• USDA Approves Hemp Plans For Six Additional States And Three Indian Tribes (Marijuana Moment)

• Virginia Bill To Ban Police Searches Based On Marijuana Smell Gets Governor-Suggested Changes (Marijuana Moment)

• Pennsylvania House Votes To Protect Medical Marijuana Patients From DUI Charges (Marijuana Moment)

LSD

• LSD: new scientific study shows microdosing elevates mood and cognition (Boing Boing)

• ‘My Psychedelic Love Story’ Review: Errol Morris’ Touching LSD Romance Adds New Dimension to Timothy Leary (IndieWire)

• Could Giving Acid to Dolphins Help Us Talk to Aliens? (DoubleBlind)

• Bill Wilson, LSD and the Secret Psychedelic History of Alcoholics Anonymous (Lucid News)

Magic Mushrooms

• First Psilocybin for Depression Clinical Trial Launched in Sweden (Psilocybin Alpha)

• Phase 2 Clinical Trial to Evaluate Safety and Efficacy of Psilocybin in Cancer Patients with Major Depressive Disorder (Psilocybin Alpha)

• Psilocybin and Mindfulness for Depression: Complementary Actions Starting to Emerge (Psychedelic Science Review)

• Pharmaceutical Startup Developing Sublingual Psilocybin Raises $34 Million To Fund Clinical Trials (Forbes)

• Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms (Psilocybin Alpha)

• Allied Expands Pharmaceutical Pipeline By Filing US Provisional Patent for Psilocybin Based Therapeutics (GlobeNewswire)

MDMA

• Government urged to sell cocaine and ecstasy in pharmacies (The Guardian)

Ayahuasca

• Ayahuasca, Capitalism and the New Age (Chacruna)

Peyote

• What Groups Are Doing to Protect Against Peyote Poaching (Green Entrepreneur)

Ketamine

• Ketamine-Induced Brain Rhythm Causes Dissociation: From Mice to Man (Psychedelic Science Review)

• Pharmather to Advance Ketamine as Potential Dyskinesia Treatment (Parkinson's News Today)

Miscellaneous

• Early Christians Might Have Been High on Hallucinogenic Communion Wine (VICE)

• People who microdose psychedelic drugs report that the benefits greatly outweigh the drawbacks (PsyPost)

• DEA recruits cite ‘monkey noises’ among claims of racism (Associated Press)

• Scientists identify a powerful anti-inflammatory compound in psychedelic drugs (Massive Science)

• Watch The Oregon Drug Decriminalization Campaign’s New TV Ads For Historic Ballot Measure (Marijuana Moment)

• 2020’s psychedelic drug ballot measures, explained (Vox)

• An Open Letter and Call to Action for MAPS Canada (Psymposia)

• Media Company Delic Corp. Announces RTO, Becomes Latest Psychedelics Company Planning to Go Public (Psilocybin Alpha)

• Jedi Flipping: What It’s Like to Mix Shrooms, Acid, and Molly (DoubleBlind)

• How to Talk to Your Therapist About Psychedelics (Psychology Today)

• “Psychedelics are Not Cotton Candy and Rainbows” with Sensei Kevon Simpson (Chacruna)

• Psyched Wellness Becomes Latest Psychedelics Company to Go Public (CSE: PSYC) (Psilocybin Alpha)

• Examining the Effects of Psychedelics on Experiential Avoidance (Psychedelic Science Review)

• Nina Graboi, A Forgotten Woman in Psychedelic Lore (Chacruna)

• Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds (Psilocybin Alpha)

• 6 Herbs to Enhance Your Next Psychedelic Trip (DoubleBlind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.